patentgrepDocs Get an API key

C12N 2310/341

Gapmers, i.e. of the type ===---===

C12N2310/341 (Gapmers, i.e. of the type ===---===) appears on 1,060 US grants and 2,083 published applications in this corpus.

Search patents in C12N

Granted patents: 1,060
Published applications: 2,083
Assignees: 371
Inventors: 1,783
Latest grant: 15 Sep 2026

Filings by year

C12N 2310/341: granted patents and published applications per publication year
Year	Granted patents	Published applications
1996	2	0
1997	5	0
1998	2	0
1999	39	0
2000	63	0
2001	50	5
2002	59	25
2003	25	183
2004	23	231
2005	15	85
2006	11	38
2007	16	49
2008	15	27
2009	20	46
2010	34	43
2011	25	47
2012	31	47
2013	30	39
2014	45	61
2015	37	71
2016	38	70
2017	49	69
2018	43	88
2019	51	81
2020	49	97
2021	57	114
2022	59	114
2023	45	112
2024	40	135
2025	50	122
2026	32	84

By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.

Recent patents

Compounds and methods for reducing FUS expression15 Sep 2026US 12,735,700 B2Ionis Pharmaceuticals, Inc.
Antagonism as a therapy for TDP-43 proteinopathies25 Aug 2026US 12,716,065 B2University of Southern California
Modulation of GYS1 expression25 Aug 2026US 12,716,067 B2Ionis Pharmaceuticals, Inc.
Processes for the production of oligonucleotides9 Jun 2026US 12,649,939 B2GlaxoSmithKline Intellectual Property Development Limited
Inhibition of lncExACT1 to treat heart disease26 May 2026US 12,637,674 B2The General Hospital Corporation

Most cited

By later US patents